Search hospitals

>

Arizona

>

Phoenix

Mayo Clinic Arizona

Claim this profile

Phoenix, Arizona 85054

Global Leader in Cancer

Global Leader in Colorectal Cancer

Conducts research for Lung Cancer

Conducts research for Breast Cancer

Conducts research for Solid Tumors

493 reported clinical trials

98 medical researchers

Photo of Mayo Clinic Arizona in PhoenixPhoto of Mayo Clinic Arizona in PhoenixPhoto of Mayo Clinic Arizona in Phoenix

Summary

Mayo Clinic Arizona is a medical facility located in Phoenix, Arizona. This center is recognized for care of Cancer, Colorectal Cancer, Lung Cancer, Breast Cancer, Solid Tumors and other specialties. Mayo Clinic Arizona is involved with conducting 493 clinical trials across 846 conditions. There are 98 research doctors associated with this hospital, such as Steven Attia, MD, Carola A. Arndt, Mahesh Seetharam, and Arkadiusz Dudek, MD.

Area of expertise

1

Cancer

Global Leader

Mayo Clinic Arizona has run 87 trials for Cancer. Some of their research focus areas include:

Stage IV
Stage III
RET
2

Colorectal Cancer

Global Leader

Mayo Clinic Arizona has run 67 trials for Colorectal Cancer. Some of their research focus areas include:

Stage IV
Stage III
KRAS positive

Top PIs

Clinical Trials running at Mayo Clinic Arizona

Breast Cancer

Skin Cancer

Lung Cancer

Bladder Cancer

Prostate Cancer

Ovarian Cancer

Cancer

Colorectal Cancer

Heart Failure

Multiple Myeloma

Image of trial facility.

Sacituzumab Govitecan + Pembrolizumab

for Triple Negative Breast Cancer

The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.

Recruiting

2 awards

Phase 3

6 criteria

Image of trial facility.

Low Dose Tamoxifen

for Breast Cancer

This phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive, HER2 negative early stage breast cancer. Tamoxifen is in a class of medications known as antiestrogens. It blocks the activity of estrogen (a female hormone) in the breast. This may stop the growth of some breast tumors that need estrogen to grow. Aromatase inhibitors, such as anastrozole, letrozole, and exemestane, prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy to treat postmenopausal women with hormone-dependent breast cancer. Giving low dose tamoxifen may be more effective compared to usual hormone therapy in treating post-menopausal women with hormone-positive, HER2 negative early stage breast cancer.

Recruiting

2 awards

Phase 3

8 criteria

Image of trial facility.

Mindfulness Approaches

for Living After Breast Cancer

NRG-CC015 is a prospective, randomized phase III clinical trial to evaluate the efficacy of two distinct digital approaches for delivering a mindfulness-based intervention: a live, instructor-led version delivered over Zoom (MAPs LO), and an app-based, self-paced version (MAPs App). Participants will include younger breast cancer survivors (BCS) who were diagnosed with breast cancer at or before age 50 years, have completed their primary cancer treatment (i.e., surgery, radiation, and/or chemotherapy) at least 6 months earlier, and report elevated depressive symptoms.

Recruiting

2 awards

Phase 3

5 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Mayo Clinic Arizona?

Where is Mayo Clinic Arizona located?

Who should I call to ask about financial aid or insurance network?

What insurance does Mayo Clinic Arizona accept?

What awards or recognition has Mayo Clinic Arizona received?